However, treatments for certain cancers have seen more progress than others. Patients with cancers such as testicular cancer,melanoma,prostate cancer,Hodgkin’s lymphoma,breast cancerand uterine cancer are surviving much longer than before. However, treatments forliver cancerandpancreatic ca...
who chairs the radiation oncology department at Johns Hopkins, who was not involved in the clinical trial. "It is much easier for patients to come in for just five treatments than to come in every single day for six weeks. It's a very positive approach, from the patient's perspective, f...
Recurrent endometrial cancerTargeted therapiesTrastuzumabUterine serous cancerPURPOSE OF REVIEW :Endometrial cancer is a highly treatable cancer; however, 13 to 15% of cases recur. Traditional cytotoxic chemotherapies have produced modest results, but new treatments show promise. This information was ...
Patients with advanced pancreatic cancer now have access to the new FDA approved drug, Onivyde, that produced significant overall survival rates in an international clinical study conducted in part by researchers at HonorHealth Research Institute and the Translational Genomics Research Institute (TGen)....
In the initial treatment of patients with multiple myeloma, Kumar emphasized that there are a lot of choices as far as individual drugs and combination regimens, but it is important to choose treatments that are tolerable and preferred by patients. Further, he emphasized the significance of not ...
Progress in the treatment of breast cancer developed along multiple directions of research during the last decade. The concept of dose-intensity was addres
But not one has been approved for clinical use in urothelial cancers. While clinical evaluation of these agents is still in its early days, some promising findings have begun to emerge. For example, everolimus demonstrated activity in those metastatic urothelial cancer patients who harbors TSC1 ...
cancer. The trial population had progressed despite treatment with platinum-based chemotherapy and immune-boosting checkpoint inhibitors, and overall had a median of 3 prior lines of therapy. Treatment with SG was followed by sustained reductions intumor sizefor 31 patients (27 percent), including ...
S241 NEW TREATMENTS FOR PATIENTS WITH LOW RISK LOCALIZED PROSTATE CANCER - ACTIVE SURVEILLANCE, FOCAL THERAPY - IS DECISION FOR DEPENDENT JUST ON UROLOGIST? O. Durutovic, M. Acimovic, N. Bojanic, P. Nikic, N. Ladjevic, A. Mimic, B. Cegar, B. Milojevic, V. Andrejevic, ...
New breast cancer guidelines mean less chemo for patients; Treatments will be targeted to specific types of tumors While several inflammatory cell types participate in cancer development, macrophages specifically play a key role in breast cancer, where they appear to be... A Press 被引量: 0发表...